翰宇药业：曾少贵累计质押股数为4719万股

Group 1 - The core point of the article is that Hanyu Pharmaceutical has reported significant share pledges by its major shareholders, indicating potential liquidity concerns [1] - As of the announcement date, the cumulative pledged shares by major shareholder Zeng Shaogui amount to 47.89% of his holdings, totaling 47.19 million shares [1] - Zeng Shaoqiang has pledged 41.97% of his holdings, totaling 26.50 million shares, while Zeng Shaobin has pledged 57.56% of his holdings, totaling 12.50 million shares [1] Group 2 - For the first half of 2025, Hanyu Pharmaceutical's revenue composition is entirely from the pharmaceutical manufacturing industry, with a 100% contribution [1] - The current market capitalization of Hanyu Pharmaceutical is 16.6 billion yuan [1]